Press & Media Coverage

Catch up on our latest press coverage

1H2023 Half-Year Results

1H2023 Highlights: Achieved enrolment target for Phase I study of MagSense® HER2 breast cancer detection; imaging results corroborated by independent panel of radiologists Announced plan

Read More

Watch our latest media coverage

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.